The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme
- 1 September 1983
- journal article
- research article
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 68 (3-4) , 239-251
- https://doi.org/10.1007/bf01401182
Abstract
Summary This report presents the results of a phase I trial of the value of human leucocyte inferon-alpha in the treatment of glioblastoma. Twelve patients entered the trial. In one case we believe that the patient benefitted from the interferon treatment. CT scans of patients on interferon did not reveal the true extent of the tumorous tissue.Keywords
This publication has 15 references indexed in Scilit:
- Human leukocyte interferon therapy for advanced ovarian carcinomaAmerican Journal of Clinical Oncology, 1982
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- Inhibition of Cell Motility by InterferonScience, 1980
- Migration of capillary endothelial cells is stimulated by tumour-derived factorsNature, 1980
- INTERFERON THERAPY IN MYELOMATOSISThe Lancet, 1979
- Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's LymphomaNew England Journal of Medicine, 1978
- Endothelial growth factor present in tissue culture of CNS tumorsJournal of Neurosurgery, 1976
- Interferon Therapy in Hodgkin's DiseaseActa Medica Scandinavica, 1976
- In Vitro Demonstration of an Endothelial Proliferative Factor Produced by Neural Cell LinesScience, 1975
- The Treatment of Glioblastoma Multiforme of the BrainJournal of Neurosurgery, 1967